Neutrophil Extracellular Traps Accumulate in Peripheral Blood Vessels and Compromise Organ Function in Tumor-Bearing Animals.

Cancer produces a variety of collateral effects in patients beyond the malignancy itself, including threats to distal organ functions. However, the basis for such effects, associated with either primary or metastatic tumors, are generally poorly understood. In this study, we show how heart and kidney vascular function is impaired by neutrophils that accumulate in those tissues as a result of tumor formation in two different transgenic mouse models of cancer (RIP1-Tag2 model of insulinoma and MMTV-PyMT model of breast cancer). Neutrophil depletion by systemic administration of an anti-Gr1 antibody improved vascular perfusion and prevented vascular leakage in kidney vessels. We also observed the accumulation of platelet-neutrophil complexes, a signature of neutrophil extracellular traps (NET), in the kidneys of tumor-bearing mice that were completely absent from healthy nontumor-bearing littermates. NET accumulation in the vasculature was associated with upregulation of the proinflammatory adhesion molecules ICAM-1, VCAM-1, and E-selectin, as well as the proinflammatory cytokines IL1β, IL6, and the chemokine CXCL1. Administering DNase I to dissolve NETs, which have a high DNA content, restored perfusion in the kidney and heart to levels seen in nontumor-bearing mice, and also prevented vessel leakage in the blood vasculature of these organs. Taken together, our findings strongly suggest that NETs mediate the negative collateral effects of tumors on distal organs, acting to impair vascular function, and to heighten inflammation at these sites.

[1]  J. Greenwood,et al.  Differential Apicobasal VEGF Signaling at Vascular Blood-Neural Barriers , 2014, Developmental cell.

[2]  C. Holmes,et al.  Platelets in Tumor Progression: A Host Factor That Offers Multiple Potential Targets in the Treatment of Cancer , 2014, Journal of cellular physiology.

[3]  J. Spicer,et al.  Neutrophil extracellular traps in cancer progression , 2014, Cellular and Molecular Life Sciences.

[4]  D. Wagner,et al.  NETosis: A New Factor in Tumor Progression and Cancer-Associated Thrombosis , 2014, Seminars in Thrombosis & Hemostasis.

[5]  E. Feuer,et al.  Assessing non-cancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence. , 2013, American journal of epidemiology.

[6]  Paul Kubes,et al.  Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis. , 2013, The Journal of clinical investigation.

[7]  D. Scadden,et al.  Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis , 2012, Proceedings of the National Academy of Sciences.

[8]  M. Aapro,et al.  Importance of monitoring renal function in patients with cancer. , 2012, Cancer treatment reviews.

[9]  A. Olsson,et al.  Platelet Regulation of Angiogenesis, Tumor Growth and Metastasis , 2012 .

[10]  Y. Carmi,et al.  IL-1α and IL-1β Recruit Different Myeloid Cells and Promote Different Stages of Sterile Inflammation , 2011, The Journal of Immunology.

[11]  P. Kubes,et al.  The neutrophil in vascular inflammation , 2011, Nature Medicine.

[12]  L. Norton,et al.  Tumor entrained neutrophils inhibit seeding in the premetastatic lung. , 2011, Cancer cell.

[13]  Matthias Kretzler,et al.  Netting Neutrophils Induce Endothelial Damage, Infiltrate Tissues, and Expose Immunostimulatory Molecules in Systemic Lupus Erythematosus , 2011, The Journal of Immunology.

[14]  J. Scheller,et al.  The pro- and anti-inflammatory properties of the cytokine interleukin-6. , 2011, Biochimica et biophysica acta.

[15]  A. M. Houghton,et al.  Tumor-associated neutrophils: new targets for cancer therapy. , 2011, Cancer research.

[16]  J. Hartwig,et al.  Extracellular DNA traps promote thrombosis , 2010, Proceedings of the National Academy of Sciences.

[17]  H. Simon,et al.  Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps , 2009, Cell Death and Differentiation.

[18]  Jun Xu,et al.  Extracellular histones are major mediators of death in sepsis , 2009, Nature Medicine.

[19]  Ole J. Halvorsen,et al.  Prosaposin inhibits tumor metastasis via paracrine and endocrine stimulation of stromal p53 and Tsp-1 , 2009, Proceedings of the National Academy of Sciences.

[20]  Z. Werb,et al.  Netting neutrophils in autoimmune small-vessel vasculitis , 2009, Nature Medicine.

[21]  C. Edelstein,et al.  Cisplatin-Induced Acute Renal Failure Is Associated with an Increase in the Cytokines Interleukin (IL)-1β, IL-18, IL-6, and Neutrophil Infiltration in the Kidney , 2007, Journal of Pharmacology and Experimental Therapeutics.

[22]  Stephen R. Clark,et al.  Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood , 2007, Nature Medicine.

[23]  R. Kaplan,et al.  Bone marrow cells in the ‘pre-metastatic niche’: within bone and beyond , 2007, Cancer and Metastasis Reviews.

[24]  Elie Azoulay,et al.  Clinical review: Specific aspects of acute renal failure in cancer patients , 2006, Critical care.

[25]  Alberto Mantovani,et al.  Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. , 2006, European journal of cancer.

[26]  R. Colvin,et al.  A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity. , 2006, Journal of the American Society of Nephrology : JASN.

[27]  S. Rafii,et al.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.

[28]  W. Holzgreve,et al.  Induction of neutrophil extracellular DNA lattices by placental microparticles and IL-8 and their presence in preeclampsia. , 2005, Human immunology.

[29]  N. Patel,et al.  Endogenous Interleukin-6 Enhances the Renal Injury, Dysfunction, and Inflammation Caused by Ischemia/Reperfusion , 2005, Journal of Pharmacology and Experimental Therapeutics.

[30]  R. Soiffer,et al.  Renal failure associated with cancer and its treatment: an update. , 2004, Journal of the American Society of Nephrology : JASN.

[31]  Gavin Thurston,et al.  Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. , 2004, The American journal of pathology.

[32]  A. Zychlinsky,et al.  Neutrophil Extracellular Traps Kill Bacteria , 2004, Science.

[33]  Jianzhong Huang,et al.  Regression of established tumors and metastases by potent vascular endothelial growth factor blockade , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. O. oude Egbrink,et al.  Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression. , 2003, Cancer research.

[35]  M. Shibuya,et al.  MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. , 2002, Cancer cell.

[36]  R. Atkins,et al.  Intrinsic renal cells are the major source of interleukin-1 beta synthesis in normal and diseased rat kidney. , 1997 .

[37]  P. Prandoni,et al.  Cancer and venous thromboembolism. , 1996, Seminars in thrombosis and hemostasis.

[38]  G. Groenewegen,et al.  Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium. , 1996, Blood.

[39]  M. E. McFadden,et al.  Multiple systems organ failure in the patient with cancer. Part I: pathophysiologic perspectives. , 1992, Oncology nursing forum.

[40]  D. Wagner,et al.  Tumorigenesis and Neoplastic Progression Innate Immune Cells Induce Hemorrhage in Tumors during Thrombocytopenia , 2010 .

[41]  Yoshiro Kobayashi The role of chemokines in neutrophil biology. , 2008, Frontiers in bioscience : a journal and virtual library.

[42]  G. Lip,et al.  Cancer and the prothrombotic state. , 2002, The Lancet. Oncology.

[43]  A. Thomson Human recombinant DNase in cystic fibrosis. , 1995, Journal of the Royal Society of Medicine.

[44]  R. Costa,et al.  Causes of death in renal transplant recipients: a study of 102 autopsies from 1968 to 1991. , 1995, Journal of the Royal Society of Medicine.

[45]  Y. Yuzawa,et al.  Expression of interleukin 6 and major histocompatibility complex molecules in tubular epithelial cells of diseased human kidneys. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[46]  E. Weinman,et al.  Acute renal failure in cancer patients. , 1992, Oncology.